300685 艾德生物
已收盘 07-23 15:00:00
资讯
新帖
简况
艾德生物(300685.SZ)与施维雅签署伴随诊断合作协议
智通财经 · 06-26
艾德生物(300685.SZ)与施维雅签署伴随诊断合作协议
艾德生物(300685.SZ):实时荧光定量PCR分析仪获医疗器械注册证
智通财经 · 06-12
艾德生物(300685.SZ):实时荧光定量PCR分析仪获医疗器械注册证
艾德生物(300685.SZ)拟10股派1.5元 于5月30日除权除息
智通财经网 · 05-23
艾德生物(300685.SZ)拟10股派1.5元 于5月30日除权除息
艾德生物(300685.SZ)与勃林格殷格翰达成伴随诊断合作 增强肿瘤精准医疗竞争力
智通财经网 · 05-22
艾德生物(300685.SZ)与勃林格殷格翰达成伴随诊断合作 增强肿瘤精准医疗竞争力
艾德生物(300685.SZ)发布一季度业绩,净利润6419.91万元 同比增加12.01%
智通财经网 · 04-22
艾德生物(300685.SZ)发布一季度业绩,净利润6419.91万元 同比增加12.01%
暂无数据
公司概况
公司名称:
厦门艾德生物医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2017-08-02
主营业务:
厦门艾德生物医药科技股份有限公司主营业务系肿瘤精准医疗分子诊断产品的研发、生产及销售,并提供相关的检测服务。公司产品主要为肿瘤精准医疗靶向用药分子诊断试剂和肿瘤化疗用药分子诊断试剂两大类,用于检测肿瘤患者相关基因状态,为临床医生制定精准医疗治疗方案提供分子诊断的参考依据。公司拥有“国家高新技术企业”、“国家企业技术中心”、“博士后科研工作站”、“专精特新‘小巨人’企业”、“国家知识产权示范企业”、“国家发改委基因检测技术应用示范中心”、“福建省肿瘤分子诊断企业工程技术研究中心”、“福建省肿瘤高通量测序工程研究中心”、“福建省科技小巨人领军企业”、“厦门市个性化分子诊断重点试验室”等资质,研发部荣获“全国工人先锋号”荣誉称号。
发行价格:
13.86
{"stockData":{"symbol":"300685","market":"SZ","secType":"STK","nameCN":"艾德生物","latestPrice":18.42,"timestamp":1721718222000,"preClose":19.21,"halted":0,"volume":2887900,"delay":0,"floatShares":394000000,"shares":399000000,"eps":0.6734,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.79,"latestTime":"07-23 15:00:00","open":19.12,"high":19.18,"low":18.41,"amount":54080900,"amplitude":0.0401,"askPrice":18.43,"askSize":20,"bidPrice":18.42,"bidSize":28,"shortable":0,"etf":0,"ttmEps":0.6734,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721784600000},"adr":0,"adjPreClose":19.21,"symbolType":"stock","openAndCloseTimeList":[[1721698200000,1721705400000],[1721710800000,1721718000000]],"highLimit":21.13,"lowLimit":17.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":398540309,"pbRate":4.32,"roa":"--","roe":"3.7%","epsLYR":0.66,"committee":-0.126697,"marketValue":7341000000,"floatMarketCap":7251000000,"peRate":27.353728,"changeRate":-0.0411,"turnoverRate":0.0073,"status":1},"requestUrl":"/m/hq/s/300685/tweets","defaultTab":"tweets","newsList":[{"id":"2446878743","title":"艾德生物(300685.SZ)与施维雅签署伴随诊断合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2446878743","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446878743?lang=zh_cn&edition=full","pubTime":"2024-06-26 11:54","pubTimestamp":1719374080,"startTime":"0","endTime":"0","summary":"据悉,施维雅是一家由基金会管理的国际集团,以服务人类健康为宗旨,期望为患者和世界可持续发展带来意义深远的社会影响。此次与施维雅达成伴随诊断合作,有利于进一步增强公司在肿瘤精准医疗市场的竞争力,将对公司未来的发展产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300685","BK0042","BK0239"],"gpt_icon":0},{"id":"2442983584","title":"艾德生物(300685.SZ):实时荧光定量PCR分析仪获医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2442983584","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442983584?lang=zh_cn&edition=full","pubTime":"2024-06-12 16:20","pubTimestamp":1718180429,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾德生物(300685.SZ)发布公告,公司于近日获得由国家药品监督管理局颁发的《中华人民共和国医疗器械注册证》,产品名称为实时荧光定量PCR分析仪,实时荧光定量PCR分析仪(GEMINI)双倍通量,操作简便快捷,具备自动报告功能,能更好的满足肿瘤精准诊断多基因联检需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1134080.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","09996","BK1100","300685","BK1583","BK0042","159883","BK1574","BK1222","BK0239"],"gpt_icon":0},{"id":"2437768617","title":"艾德生物(300685.SZ)拟10股派1.5元 于5月30日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2437768617","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437768617?lang=zh_cn&edition=full","pubTime":"2024-05-23 21:55","pubTimestamp":1716472537,"startTime":"0","endTime":"0","summary":"艾德生物(300685.SZ)公告,公司2023年度权益分派拟:向全体股东每10股...","market":"us","thumbnail":"https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/8.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1125455.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300685","BK0239","BK0042"],"gpt_icon":0},{"id":"2437566582","title":"艾德生物(300685.SZ)与勃林格殷格翰达成伴随诊断合作 增强肿瘤精准医疗竞争力","url":"https://stock-news.laohu8.com/highlight/detail?id=2437566582","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437566582?lang=zh_cn&edition=full","pubTime":"2024-05-22 16:48","pubTimestamp":1716367686,"startTime":"0","endTime":"0","summary":"勃林格殷格翰致力于研究突破性疗法,旨在变革生命,守护世世代代的健康。作为一家研发驱动的全球领先生物制药企业,勃林格殷格翰在医疗需求高度未得到满足的领域通过创新展现价值。此次与勃林格殷格翰达成伴随诊断合作,有利于进一步增强公司在肿瘤精准医疗市场的竞争力,将对公司未来的发展产生积极影响。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1124486.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","BK0042","300685"],"gpt_icon":0},{"id":"2429919441","title":"艾德生物(300685.SZ)发布一季度业绩,净利润6419.91万元 同比增加12.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429919441","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429919441?lang=zh_cn&edition=full","pubTime":"2024-04-22 16:00","pubTimestamp":1713772817,"startTime":"0","endTime":"0","summary":"智通财经APP讯,艾德生物(300685.SZ)发布2024年一季度报告,报告期内公司实现营业收入2.33亿元,同比增加19.53%;归属于上市公司股东的净利润6419.91万元,同比增加12.01%;归属于上市公司股东的扣除非经常性损益的净利润5698.19万元,同比增加26.44%;基本每股收益0.16元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300685"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-08-02","address":"福建省厦门市海沧区鼎山路39号","stockEarnings":[{"period":"1week","weight":-0.0065},{"period":"1month","weight":0.0033},{"period":"3month","weight":-0.1313},{"period":"6month","weight":-0.0194},{"period":"1year","weight":-0.2281},{"period":"ytd","weight":-0.155}],"companyName":"厦门艾德生物医药科技股份有限公司","boardCode":"AI0027","perCapita":"21364股","boardName":"医药制造业","registeredCapital":"39854万元","compareEarnings":[{"period":"1week","weight":-0.0205},{"period":"1month","weight":-0.0276},{"period":"3month","weight":-0.0425},{"period":"6month","weight":0.0032},{"period":"1year","weight":-0.0786},{"period":"ytd","weight":-0.02}],"survey":" 厦门艾德生物医药科技股份有限公司主营业务系肿瘤精准医疗分子诊断产品的研发、生产及销售,并提供相关的检测服务。公司产品主要为肿瘤精准医疗靶向用药分子诊断试剂和肿瘤化疗用药分子诊断试剂两大类,用于检测肿瘤患者相关基因状态,为临床医生制定精准医疗治疗方案提供分子诊断的参考依据。公司拥有“国家高新技术企业”、“国家企业技术中心”、“博士后科研工作站”、“专精特新‘小巨人’企业”、“国家知识产权示范企业”、“国家发改委基因检测技术应用示范中心”、“福建省肿瘤分子诊断企业工程技术研究中心”、“福建省肿瘤高通量测序工程研究中心”、“福建省科技小巨人领军企业”、“厦门市个性化分子诊断重点试验室”等资质,研发部荣获“全国工人先锋号”荣誉称号。","serverTime":1721776718086,"listedPrice":13.86,"stockholders":"18425人(较上一季度增加3.30%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾德生物(300685)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾德生物(300685)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾德生物,300685,艾德生物股票,艾德生物股票老虎,艾德生物股票老虎国际,艾德生物行情,艾德生物股票行情,艾德生物股价,艾德生物股市,艾德生物股票价格,艾德生物股票交易,艾德生物股票购买,艾德生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾德生物(300685)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾德生物(300685)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}